These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 23030005)
21. Antiproliferative effect of silver nanoparticles synthesized using amla on Hep2 cell line. Rosarin FS; Arulmozhi V; Nagarajan S; Mirunalini S Asian Pac J Trop Med; 2013 Jan; 6(1):1-10. PubMed ID: 23317879 [TBL] [Abstract][Full Text] [Related]
22. Phytosynthesis of silver nanoparticles using Artemisia marschalliana Sprengel aerial part extract and assessment of their antioxidant, anticancer, and antibacterial properties. Salehi S; Shandiz SA; Ghanbar F; Darvish MR; Ardestani MS; Mirzaie A; Jafari M Int J Nanomedicine; 2016; 11():1835-46. PubMed ID: 27199558 [TBL] [Abstract][Full Text] [Related]
23. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Kawata K; Osawa M; Okabe S Environ Sci Technol; 2009 Aug; 43(15):6046-51. PubMed ID: 19731716 [TBL] [Abstract][Full Text] [Related]
24. Thermosensitive drug-loading system based on copper sulfide nanoparticles for combined photothermal therapy and chemotherapy in vivo. Yuan Z; Qu S; He Y; Xu Y; Liang L; Zhou X; Gui L; Gu Y; Chen H Biomater Sci; 2018 Nov; 6(12):3219-3230. PubMed ID: 30255863 [TBL] [Abstract][Full Text] [Related]
25. Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells. Rui M; Qu Y; Gao T; Ge Y; Feng C; Xu X Int J Nanomedicine; 2017; 12():217-237. PubMed ID: 28115844 [TBL] [Abstract][Full Text] [Related]
26. Cytochrome c - silver nanoparticle interactions: Spectroscopy, thermodynamic and enzymatic activity studies. Liu W; Berge-Lefranc D; Chaspoul F; Slaveykova VI Chem Biol Interact; 2023 Sep; 382():110647. PubMed ID: 37499996 [TBL] [Abstract][Full Text] [Related]
27. Dual functions of silver nanoparticles in F9 teratocarcinoma stem cells, a suitable model for evaluating cytotoxicity- and differentiation-mediated cancer therapy. Han JW; Gurunathan S; Choi YJ; Kim JH Int J Nanomedicine; 2017; 12():7529-7549. PubMed ID: 29066898 [TBL] [Abstract][Full Text] [Related]
28. Binding behaviors and kinetics studies on the interaction of silver nanoparticles with trypsin. Li X; Yan Y; Cheng X; Guo W; Peng Y Int J Biol Macromol; 2018 Jul; 114():836-843. PubMed ID: 29605250 [TBL] [Abstract][Full Text] [Related]
29. Guazuma ulmifolia bark-synthesized Ag, Au and Ag/Au alloy nanoparticles: Photocatalytic potential, DNA/protein interactions, anticancer activity and toxicity against 14 species of microbial pathogens. Karthika V; Arumugam A; Gopinath K; Kaleeswarran P; Govindarajan M; Alharbi NS; Kadaikunnan S; Khaled JM; Benelli G J Photochem Photobiol B; 2017 Feb; 167():189-199. PubMed ID: 28076823 [TBL] [Abstract][Full Text] [Related]
30. pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin. Yang S; Tang Z; Zhang D; Deng M; Chen X Biomater Sci; 2017 Sep; 5(10):2169-2178. PubMed ID: 28914292 [TBL] [Abstract][Full Text] [Related]
31. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition. Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976 [TBL] [Abstract][Full Text] [Related]
32. Synthesis, characterization, biocompatible and anticancer activity of green and chemically synthesized silver nanoparticles - A comparative study. Kummara S; Patil MB; Uriah T Biomed Pharmacother; 2016 Dec; 84():10-21. PubMed ID: 27621034 [TBL] [Abstract][Full Text] [Related]
33. Biomimetic synthesis of silver nanoparticles using Matricaria chamomilla extract and their potential anticancer activity against human lung cancer cells. Dadashpour M; Firouzi-Amandi A; Pourhassan-Moghaddam M; Maleki MJ; Soozangar N; Jeddi F; Nouri M; Zarghami N; Pilehvar-Soltanahmadi Y Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():902-912. PubMed ID: 30184820 [TBL] [Abstract][Full Text] [Related]
34. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery. Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197 [TBL] [Abstract][Full Text] [Related]
35. Charge-conversional PEG-polypeptide polyionic complex nanoparticles from simple blending of a pair of oppositely charged block copolymers as an intelligent vehicle for efficient antitumor drug delivery. Lv S; Song W; Tang Z; Li M; Yu H; Hong H; Chen X Mol Pharm; 2014 May; 11(5):1562-74. PubMed ID: 24606535 [TBL] [Abstract][Full Text] [Related]
36. Silver nanoparticle-embedded graphene oxide-methotrexate for targeted cancer treatment. Thapa RK; Kim JH; Jeong JH; Shin BS; Choi HG; Yong CS; Kim JO Colloids Surf B Biointerfaces; 2017 May; 153():95-103. PubMed ID: 28231500 [TBL] [Abstract][Full Text] [Related]
37. Intercalation of antitumor drug doxorubicin and its analogue by DNA duplex: structural features and biological implications. Agudelo D; Bourassa P; Bérubé G; Tajmir-Riahi HA Int J Biol Macromol; 2014 May; 66():144-50. PubMed ID: 24560949 [TBL] [Abstract][Full Text] [Related]
38. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition. Gao M; Xu Y; Qiu L J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110 [TBL] [Abstract][Full Text] [Related]
39. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer. Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487 [TBL] [Abstract][Full Text] [Related]
40. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer. Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]